Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:26:13.538Z.
Calculation as of: 2026-10-06T14:26:13.538Z.
Quote observation: 2026-10-06T14:25:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b2d28e84da0c930e75004ae600b803967d1975629f72cad3bf33ad83c9831f21
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Eikon Therapeutics, Inc. Common Stock
Market Cap
$411.99M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$412.27M
Operating Cash Flow Yield
1.87%
TTM Avg
1.03%
3Y Avg
1.03%
5Y Avg
0.91%
Market Cap
$406.54M
Operating Cash Flow Yield
N/A
TTM Avg
24.51%
3Y Avg
24.51%
5Y Avg
24.51%
Market Cap
$407.09M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$425.86M
Operating Cash Flow Yield
N/A
TTM Avg
1.96%
3Y Avg
1.96%
5Y Avg
1.96%
Market Cap
$432.69M
Operating Cash Flow Yield
N/A
TTM Avg
7.13%
3Y Avg
7.13%
5Y Avg
7.13%
Market Cap
$437.27M
Operating Cash Flow Yield
N/A
TTM Avg
28.93%
3Y Avg
28.93%
5Y Avg
28.93%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. Common Stock (EIKN) | $411.99M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $412.27M | 1.87% | 1.03% | 1.03% | 0.91% |
| Carlsmed, Inc. (CARL)vs › | $408.32M | N/A | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $406.54M | N/A | 24.51% | 24.51% | 24.51% |
| Shoulder Innovations, Inc. (SI)vs › | $407.09M | N/A | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $402.01M | N/A | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $425.86M | N/A | 1.96% | 1.96% | 1.96% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $432.69M | N/A | 7.13% | 7.13% | 7.13% |
| Assembly Biosciences, Inc. (ASMB)vs › | $437.27M | N/A | 28.93% | 28.93% | 28.93% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $384.04M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
